Literature DB >> 7071126

Anticonvulsant effects of the (-) and (+)isomers of cannabidiol and their dimethylheptyl homologs.

J R Leite, E A Carlini, N Lander, R Mechoulam.   

Abstract

The anticonvulsant actions of the (-) and (+)isomers of cannabidiol and dimethylheptyl-cannabidiol were studied with the maximal electroconvulsive shock model in mice. The ratio of the times for hindlimb extension and fore limb flexion was recorded as an anticonvulsant index. All the cannabinoids were anticonvulsant. They also potentiated pentobarbitone sleeping time. The (+)isomer was more active than the (-)isomer. Possible mechanisms of actions on receptors or membranes are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7071126     DOI: 10.1159/000137588

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  7 in total

Review 1.  Pediatric Concerns Due to Expanded Cannabis Use: Unintended Consequences of Legalization.

Authors:  George Sam Wang
Journal:  J Med Toxicol       Date:  2016-05-02

Review 2.  Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.

Authors:  Maureen L Petrunich-Rutherford; Michael W Calik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Factors that lead to the use of crack cocaine in combination with marijuana in Brazil: a qualitative study.

Authors:  Janaina R Gonçalves; Solange A Nappo
Journal:  BMC Public Health       Date:  2015-07-25       Impact factor: 3.295

Review 4.  An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

Authors:  Paula Morales; Patricia H Reggio; Nadine Jagerovic
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

5.  Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures.

Authors:  Mark Mascal; Nema Hafezi; Deping Wang; Yuhan Hu; Gessica Serra; Mark L Dallas; Jeremy P E Spencer
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

Review 6.  From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?

Authors:  Rafael M Bitencourt; Reinaldo N Takahashi; Elisaldo A Carlini
Journal:  Front Psychiatry       Date:  2021-02-11       Impact factor: 4.157

Review 7.  Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

Authors:  Emilio Perucca
Journal:  J Epilepsy Res       Date:  2017-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.